Skip to content

Starting ART immediately after HIV diagnosis cuts mortality risk by two-thirds for people with high CD4 cell counts

Symtuza as effective as multi-pill combination in previously untreated people with HIV

Chloe Orkin presenting at EACS 2017. Image credit: Francesc Martínez, gTt-VIH.org

Fostemsavir controls viral load in half of people with highly drug-resistant HIV

Fostemsavir presentation by Max Lataillade at EACS 2017. Image credit: @chloe_orkin

People with HIV still expect a lower quality of life than their negative peers, European survey finds

Shutterstock Studios HIV in View gallery

New EACS treatment guidelines

New EACS treatment guidelines

ABX464 reduces HIV reservoir but doesn’t delay viral rebound

Linos Vandekerckhove presenting at EACS 2017. Photo by BHIVA.

Boosted protease inhibitor and lamivudine provides effective maintenance treatment

Boosted protease inhibitor and lamivudine provides effective maintenance treatment

Symtuza protease inhibitor regimen maintains viral suppression for a year

Long-acting monoclonal antibody effective against multidrug-resistant HIV